Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lübbert

Showing results (61-70 of 119) with videos related to

Pageof 12
Sort By:
Leukemia|August 1, 1996
HTLV-I-associated adult T cell leukemia/lymphoma in two patients from Bucharest, RomaniaH Veelken, G Köhler, J Schneider, et al.
Leukemia Research|October 23, 1998
Drug resistance of secondary acute myeloid leukemia with megakaryoblastic features and p190 BCR-ABL rearrangementH Veelken, T Licht, A Lais, et al.
BMC Medical Genomics|June 27, 2021
Repeat to gene expression ratios in leukemic blast cells can stratify risk prediction in acute myeloid leukemiaM Onishi-Seebacher, G Erikson, Z Sawitzki, et al.
Annals of Hematology|May 21, 2003
Prognosis of older patients with acute myeloid leukemia receiving either induction or noncurative treatment: a single-center retrospective studyB Behringer, J A Pitako, R Kunzmann, et al.
Bone Marrow Transplantation|March 17, 2015
5-Azacytidine and DLI can induce long-term remissions in AML patients relapsed after allograftJ Steinmann, H Bertz, R Wäsch, et al.
British Journal of Haematology|September 1, 2001
Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidineM Lübbert, P Wijermans, R Kunzmann, et al.
Leukemia|April 4, 2008
Two cell lines of t(8;21) acute myeloid leukemia with activating KIT exon 17 mutation: models for the 'second hit' hypothesisH Becker, D Pfeifer, J D Afonso, et al.
Blood|February 15, 1992
Clonal analysis of bcr-abl rearrangement in T lymphocytes from patients with chronic myelogenous leukemiaD Jonas, M Lübbert, E S Kawasaki, et al.
Oncogene|April 1, 1990
Retrospective analysis of ras gene activation in myeloid leukemic cellsM Lübbert, D Jonas, C W Miller, et al.
Cytokines and Molecular Therapy|June 1, 1995
Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alphaT Licht, M Lübbert, C Martens, et al.
Pageof 12

Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
Leukemia|August 1, 1996
HTLV-I-associated adult T cell leukemia/lymphoma in two patients from Bucharest, RomaniaH Veelken, G Köhler, J Schneider, et al.
Leukemia Research|October 23, 1998
Drug resistance of secondary acute myeloid leukemia with megakaryoblastic features and p190 BCR-ABL rearrangementH Veelken, T Licht, A Lais, et al.
BMC Medical Genomics|June 27, 2021
Repeat to gene expression ratios in leukemic blast cells can stratify risk prediction in acute myeloid leukemiaM Onishi-Seebacher, G Erikson, Z Sawitzki, et al.
Annals of Hematology|May 21, 2003
Prognosis of older patients with acute myeloid leukemia receiving either induction or noncurative treatment: a single-center retrospective studyB Behringer, J A Pitako, R Kunzmann, et al.
Bone Marrow Transplantation|March 17, 2015
5-Azacytidine and DLI can induce long-term remissions in AML patients relapsed after allograftJ Steinmann, H Bertz, R Wäsch, et al.
British Journal of Haematology|September 1, 2001
Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidineM Lübbert, P Wijermans, R Kunzmann, et al.
Leukemia|April 4, 2008
Two cell lines of t(8;21) acute myeloid leukemia with activating KIT exon 17 mutation: models for the 'second hit' hypothesisH Becker, D Pfeifer, J D Afonso, et al.
Blood|February 15, 1992
Clonal analysis of bcr-abl rearrangement in T lymphocytes from patients with chronic myelogenous leukemiaD Jonas, M Lübbert, E S Kawasaki, et al.
Oncogene|April 1, 1990
Retrospective analysis of ras gene activation in myeloid leukemic cellsM Lübbert, D Jonas, C W Miller, et al.
Cytokines and Molecular Therapy|June 1, 1995
Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alphaT Licht, M Lübbert, C Martens, et al.
Pageof 12